RN Mobile Menu


Rheumatoid Arthritis

How well does belimumab work in your lupus patients?

Research shows that belimumab is working in lupus. Learn more and share your story during Thursday's #RheumJC Twitter chat. (Pictured here is IgG1 monoclonal antibody, the basis for belimumab. @molekuul.be/Shutterstock.com)

Rheumatoid Arthritis

Eric Morand, M.D., PhD.

Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.


Study shows that 14-3-3η protein serum levels can more accurately identify patients with early polyarthritis at risk for long-term poor outcomes.

Seth Lederman M.D.

Profiles in Rheumatology: Seth Lederman, M.D., chairman and CEO of Tonix Pharmaceuticals

A new study recommends that only a small minority of rheumatoid arthritis patients who are in clinical remission should discontinue adalimumab.


In early rheumatoid arthritis, disease activity and pain do not necessarily occur in parallel.


Tocilizumab added to methotrexate suppresses inflammation as compared to tocilizumab alone after inadequate methotrexate response.

Review confirms increased risk of atrial fibrillation in rheumatoid arthritis patients.


Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.